Note: Ingredients listed on restricted chemical lists
EC/CAS
7681-49-4
Name of the chemical
Sodium fluoride
Concentration
N/A
EC/CAS
231-667-8
Name of the chemical
Sodium fluoride
Concentration
N/A
General Information
Revision date
2020-04-06
Product name
NovoCyte Starter Kit V2, Part Number 8100002
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
Agilent Technologies Manufacturing GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
pdl-msds_author@agilent.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
Product definition
NovoFlow solution Mixture NovoRinse solution Mixture NovoCyte QC Particles Mixture (generation 2)
CLP CLASSIFICATION
NovoFlow solution H373 SPECIFIC TARGET ORGAN TOXICITY - REPEATED EXPOSURE Ingredients of unknown : NovoFlow solution Percentage of the mixture consisting of ingredient(s) of toxicity unknown acute dermal toxicity: 10 - 30% See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
Hazard pictograms
NovoFlow solution
Signal word
NovoFlow solution Warning NovoRinse solution No signal word. NovoCyte QC Particles No signal word. (generation 2)
Hazard statements
NovoFlow solution H373 - May cause damage to organs through prolonged or repeated exposure. NovoRinse solution No known significant effects or critical hazards. NovoCyte QC Particles No known significant effects or critical hazards. (generation 2)
Prevention
NovoFlow solution P260 - Do not breathe vapour. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)
Response
NovoFlow solution P314 - Get medical advice/attention if you feel unwell. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)
Storage
NovoFlow solution Not applicable. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)
Disposal
NovoFlow solution P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)
Hazardous Ingredients
NovoFlow solution - Acetic acid, (ethylenedinitrilo)tetra-, disodium salt, dihydrate
Supplemental label elements
NovoFlow solution Not applicable. elements NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2) Annex XVII - Restrictions : NovoFlow solution Not applicable. on the manufacture, NovoRinse solution Not applicable. placing on the market NovoCyte QC Particles Not applicable. and use of certain (generation 2) dangerous substances, mixtures and articles
Special packaging requirements
Tactile warning of NovoFlow solution Not applicable. danger NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)
2.3 Other hazards
Product meets the : NovoFlow solution This mixture does not contain any substances that are criteria for PBT or vPvB assessed to be a PBT or a vPvB. according to NovoRinse solution This mixture does not contain any substances that are Regulation (EC) No. assessed to be a PBT or a vPvB. 1907/2006, Annex XIII NovoCyte QC Particles This mixture does not contain any substances that are (generation 2) assessed to be a PBT or a vPvB. Other hazards which do : NovoFlow solution None known. not result in NovoRinse solution None known.
Classifications
NovoCyte QC Particles None known. (generation 2)